Questions answered
Questions this site answers
Each question below is answered in full by one article. Short answers first, so you can find what you need before reading further.
What do repeated user workarounds indicate in medical device design?
Repeated user workarounds signal unrecognised design requirements rather than mere non-compliance or poor training. They reveal system limitations where workflows clash with clinical reality, interfaces demand excessive effort, or information is mistimed. Human factors methods, including observation and task analysis, help identify where a medical device design inappropriately shifts the operational burden to the user.
Read: A workaround is often a design requirement that has not been recognized yet.
Can a clinical trial replace human factors validation testing for medical devices?
A clinical trial cannot automatically replace human factors validation. Clinical trials focus on therapeutic efficacy and clinical safety using tightly controlled conditions. In contrast, human factors validation requires representative users, realistic environments, and minimal investigator intervention to capture use errors. Blending them requires deliberately designing the protocol to meet specific human factors validation requirements.
Why does human factors prioritise severity over probability for use errors?
Human factors prioritises severity over probability because reliable data on use errors is rarely available. Complaints underreport use errors, and simulated studies lack the sample size for meaningful probability calculations. Consequently, low probability cannot justify accepting a use error risk, meaning potential harm severity must drive risk mitigation decisions.
Read: Probability of occurrence. Risk vs HFE interpretationBest practices
What are the key updates to FDA's human factors guidance for medical devices?
The revised FDA guidance aligns human factors engineering with the Quality Management System Regulation and ISO 13485:2016. It ensures human factors outputs integrate directly into design inputs and risk controls rather than late-stage validation. Terminology is updated to match international standards, whilst specific submission reporting outlines are moved to separate guidance.
What are the challenges of using existing evidence for FDA Category 2 human factors submissions?
Category 2 submissions test whether risk controls remain effective over time. Challenges arise when use-related risk assessments, complaint records, post-market data, and design changes are stored in disconnected systems. Additionally, use errors are often poorly captured or misclassified as technical failures, making it difficult to demonstrate ongoing safety without continuous lifecycle evidence.
Why is the URRA central to FDA human factors medical device submissions?
The Use-Related Risk Analysis sits at the centre of determining what human factors information the FDA requires. It identifies critical tasks, evaluates modifications, and assesses risk control effectiveness. Regulators view it as a living document that must be continuously updated with user feedback and post-market data rather than treated as a static submission checklist.
What does human factors maturity look like in medical device development?
Human factors maturity means integrating user needs, risk reviews, design decisions, formative research, and post-market data across all development phases to improve safety. Rather than treating validation as a regulatory checklist hurdle before submission, mature organisations embed this mindset from the beginning, making regulatory evidence a natural outcome of good design.
Read: We talk a lot about quality maturity in medical device companies. Why don't we talk about Human Factors maturity the same way?Best practices
What criteria does FDA Decision Point D use to evaluate human factors validation data?
Decision Point D evaluates whether human factors validation test data must be submitted based on user interface history of use, user interface complexity, and adequacy of existing risk controls. To support this pathway, manufacturers require robust objective evidence, including clean risk analyses, full traceability, known use problems, and connected post-market complaint signals.
Read: New FDA guidance marketing authorization decision point DRegulation
What sample size is required for formative and summative human factors studies?
Sample size depends on your research method and objectives. Formative evaluations typically require five to eight participants per user group to detect frequent usability issues. For summative validation studies, the FDA usually looks for at least fifteen participants per user group. Broader methods like surveys or workflow observations require sample sizes matched to the specific research question.
How does FDA human factors guidance differ from IEC 62366-1 for medical devices?
While IEC 62366-1 outlines the general usability engineering process, the FDA requires specific US submission criteria. Key differences include expecting at least 15 participants per user group, using US-resident participants, testing US-marketed labelling and training, providing explicit critical task analyses, and following a recommended structure for the human factors engineering report.
Read: FDA guidance in human factors for medical devices from CDRHRegulation
What are affordances in medical device design?
Affordances are design clues indicating how a device should be used, showing users what to press, pull, connect, or hold. They can be physical, visual, tactile, auditory, or digital. Effective affordances guide users directly at the point of use, reducing uncertainty and preventing potential harm without relying heavily on instructions.
Is medical device summative usability testing a pass or fail test?
Summative usability testing is not a pass or fail event based on error counts. Real users inevitably make mistakes, so success relies on analysing root causes, demonstrating that identified use risks are adequately controlled, and providing evidence that design decisions throughout development have minimised risk for the intended setting.
How are critical tasks defined in medical device human factors?
A critical task is determined by the consequences of user error rather than task complexity. Any action where failure could lead to injury, incorrect dosing, or interrupted therapy is critical. Regulatory definitions differ: some authorities focus strictly on serious harm, while others include therapy delays and any level of harm.
Why is plain language important in medical device labelling?
Plain language ensures instructions, warnings, and interface text are easily understood and actionable without sacrificing accuracy. Because users may be stressed, tired, or in pain, complex terminology increases the risk of use error. Clear communication reduces cognitive effort, supports safe device use, meets regulatory expectations, and builds user confidence.
Why is managing cognitive load critical in medical device design?
Cognitive load is the mental effort required to operate a device. Working memory holds only three to five items, and exceeding this capacity leads to overload and mistakes. High cognitive load causes eighty per cent of medical device user errors. Designers reduce this risk by removing unnecessary steps, simplifying instructions, and providing clear visual cues.
How are critical tasks defined in medical device human factors?
Critical tasks are defined by consequence rather than difficulty, occurring when getting a task wrong could cause harm. For medical devices reviewed by the CDRH, critical tasks involve potential serious harm. For combination products reviewed by DMEPA, they cover any potential harm, including underdose, overdose, or missed doses disrupting treatment.
Why is a medical device summative evaluation not a pass or fail test?
Summative evaluation is not based on error counts or numerical pass thresholds. Instead, it relies on investigating root causes to determine whether observed use errors are adequately controlled or indicate unresolved design issues. It acts as a confirmation that critical risks were properly understood, addressed, and supported with evidence throughout development.
What are the human factors requirements under the EU MDR?
The EU Medical Device Regulation embeds human factors expectations into requirements regarding intended use, reasonably foreseeable misuse, ergonomic characteristics, and use environments. Manufacturers must demonstrate an understanding of real users before designs are fixed, using the IEC 62366-1 framework to connect usability engineering to risk management and provide evidence of safe, effective use.
Why is mitigating medical device risks through the IFU considered weak?
Mitigating use-related risks in the IFU shifts the burden onto users rather than resolving design flaws. Under IEC 62366, information for safety requires evidence that users perceive, understand, and follow instructions under pressure. Because users frequently miss or misinterpret text, relying on manuals leaves manufacturers exposed to potential use errors.
Read: Why mitigating in IFU is not a good ideaBest practices
Why is understanding user behaviour crucial in medical device human factors?
Human factors engineering requires understanding why users interact with a device in specific ways, especially when distracted, tired, or under pressure. Rather than simply documenting errors or task completion, identifying the behavioural causes behind use-related risks enables teams to design out risks and prevent safety problems before validation testing.
Read: HF must understand why users do somethingBest practices
What is the hierarchy of risk control measures for medical devices?
Under ISO 14971 and IEC 62366, the risk control hierarchy prioritises design changes, followed by protective measures, and lastly information for safety. Engineering out risks eliminates hazards directly. Protective measures reduce risk but leave hazards present, whilst information like warnings and instructions is the weakest control because it relies entirely on user behaviour.
Read: Different control measures and how it impactsBest practices
Why should medical device teams not rely solely on simulated usability testing?
Relying solely on simulated usability testing means discovering usability problems too late, when design changes are difficult to justify. Applying varied IEC 62366 human factors methods earlier allows teams to understand users, workflows, environments, tasks, and risks beforehand. Selecting the appropriate method at each development stage prevents waiting until validation to address user struggles.
Does human factors depend on medical device regulatory class?
Human factors is not tied to regulatory classification. Regulators can request evidence of how use-related risks are addressed even for lower-class devices and drug products. While the depth and rigour of the human factors process scale with the risk of harm, applying usability principles ensures safe, effective use and better market adoption.
Read: HF is independent of regulatory categorization Regulation
Why are mental models important in medical device design?
A mental model is the user's internal picture of how a system works. In medical device design, matching the layout, feedback, and behaviour to this model helps users predict outcomes and execute operational sequences accurately. Designing around the user's mental model provides essential safety, predictability, and confidence during real-world device use.
Read: MedTech Human Factors for Everyone - Mental modelsConcepts
How do medical device human factors requirements differ between the FDA, EU MDR, and NMPA?
The FDA evaluates whether intended US users can complete critical tasks safely, whilst China's NMPA scrutinises data transferability across local user characteristics and clinical practices. Under EU MDR, Notified Bodies increasingly demand rigorous usability evidence linked to safety and performance. Medical device teams must justify human factors transferability rather than assuming evidence applies globally.
Read: Different regions different requirements but same goalsRegulation
Why is design consistency important in medical device interfaces?
Design consistency in medical devices ensures symbols, colours, and interface cues behave predictably, allowing users to operate without unnecessary cognitive load. Inconsistent design forces users to question visual cues, increasing the risk of error. Changes to established conventions must be intentional and evidence-based, as confusion is dangerous in high-risk environments.
Does regulation slow down innovation in medical device development?
Regulation does not inherently slow innovation; delays happen when teams develop devices without understanding regulatory expectations. Leaving Human Factors until validation leads to reactive fixes and expensive surprises. Companies clear regulation more smoothly by identifying usability risks early, iterating designs, and treating human factors as an integral part of ongoing development.
Read: Regulators are not the problem for innovationRegulation
What happens if human factors is delayed in medical device development?
Postponing human factors in medical device development frequently leads to regulatory issues with the FDA. Because usability is directly tied to device design, late-stage fixes are not quick patches. They typically require interface redesigns, additional development, revised risk assessments, and further testing, resulting in substantial costs and severe project delays.
What are the risks of hiring human factors experts late in medical device development?
Hiring human factors experts after design lock leaves predictable use errors built into the system. Instead of shaping the device, late involvement forces teams into damage reduction. This frequently leads to costly redesigns, complicated instructions for use, weak risk mitigations, project timeline delays, and increased regulatory submission risk.
Why does leading language slip into human factors usability scripts?
Leading language frequently appears in human factors summative protocols because everyday conversational habits naturally contain subtle bias. Practitioners unintentionally transfer these speaking patterns into testing scripts without realising it. Addressing this issue requires actively recognising these linguistic habits, which can be achieved by studying common logical fallacies to prevent biasing participants during testing.
Why should user physical capabilities be considered early in medical device design?
Medical device design must incorporate users' physical capabilities, such as force limits, vision, hearing, and component manipulation, especially for home-use products. Designing based solely on technical aspects risks failing user needs. Understanding these realistic physical constraints upfront ensures usability actively drives design choices rather than merely justifying decisions after the fact.